CVS says GLP-1s save money when priced below $350 per month
CVS said lower emergency room and hospitalization use can offset drug costs for some patients, but sponsors still paid $3,900 more per person over three years.
4 Articles
4 Articles
CVS says GLP-1s save money when priced below $350 per month - Regional Media News
By Amina Niasse NEW YORK, Nov 14 (Reuters) - CVS Health said employers and other health plan sponsors could break even on GLP-1 drugs if they are priced below $350 per month as reduced use of medical services, such as hospitalizations and emergency room visits, [...]
CVS says GLP-1s save money when priced below $350 per month
By Amina Niasse NEW YORK, Nov 14 (Reuters) - CVS Health said employers and other health plan sponsors could break even on GLP-1 drugs if they are priced below $350 per month as reduced use of medical services, such as hospitalizations and emergency roo...
GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are associated with fewer emergency room visits and hospitalizations, but at current prices they still increase total payer spending, according to an analysis by CVS Health. The company estimates that at prices below $350 per month, the savings in healthcare costs could offset the cost of the therapy.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
